Annual Drug Patent Expirations for ZMAX
Zmax is a drug marketed by Pf Prism Cv and is included in one NDA. There are two patents protecting this drug.
This drug has forty-seven patent family members in forty-three countries.
The generic ingredient in ZMAX is azithromycin. Additional details are available on the azithromycin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
